Q2 Earnings Highlights: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks
5 Insightful Analyst Questions From agilon health’s Q2 Earnings Call
Agilon Health (AGL) Q2 2026 Earnings Call Transcript
Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year?
Citigroup Upgrades agilon health (AGL)
Wells Fargo Maintains Overweight on Agilon Health, Raises Price Target to $146
Citigroup Upgrades Agilon Health to Neutral, Raises Price Target to $115
Can agilon health (AGL) Justify Its Valuation As Earnings Turned Profitable?
agilon health: The Q2 Inflection Is Real
Truist Securities Maintains Hold on Agilon Health, Raises Price Target to $112
Benchmark Maintains Buy on Agilon Health, Raises Price Target to $140
Evercore ISI Group Maintains In-Line on Agilon Health, Raises Price Target to $125
Barclays Maintains Equal-Weight on Agilon Health, Raises Price Target to $111
agilon health, inc. (AGL) Q2 2026 Earnings Call Transcript
Agilon Health Q2 Earnings Call Highlights
Agilon Health (AGL) Tops Q2 Earnings and Revenue Estimates
Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Agilon Health (NYSE:AGL) Beats Q2 Estimates and Raises Full-Year Guidance
agilon health (NYSE:AGL) Beats Q2 CY2026 Sales Expectations, Full-Year Sales Guidance is Optimistic
agilon health Reports Second Quarter 2026 Results
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.